PTGIR and pulmonary arterial hypertension: 2) Prostacyclin pathway: We found that CECs have reduced gene expression of the prostacyclin receptor (PTGIR) (log2FC = -1.46, pAdj = 0.02), consistent with the reduced levels observed in PAH patients [54].